Abvance Therapeutics
Reno
About Abvance Therapeutics
Abvance Therapeutics is a biotechnology research company that focuses on innovative solutions to address unmet needs in diabetes care. The company is known for developing a novel coformulation of insulin and glucagon, which could revolutionize diabetes care. This treatment combines two well-understood and FDA-approved peptides to control glycemia while mitigating the threat of hypoglycemia. The company's team of scientists and physicians have discovered this unique approach to diabetes treatment, aiming to reduce hypoglycemia and improve patient outcomes.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Funding stage: Seed
- Last round: Seed (Jun 2025)
- Website: abvancetherapeutics.com
- Phone: [email protected]
Industries & Categories
Health Care, Personal Health, Therapeutics, Wellness
Social Profiles
Canonical: https://fsome.com/organization/abvance-therapeutics-177898 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.